Antiviral Drugs Market Size & Share, by Drug Class - (DNA Polymerase, Reverse Transcription, Protease, Neuraminidase Inhibitors); Indication - (Influenza, HIV, AIDS, Hepatitis, Harper Simplex Virus (HSV), Coronavirus Infection); Type - (Branded, Generic); Age Group - (Pediatric, Adult, Geriatric) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2033

  • Report ID: 473
  • Published Date: Feb 13, 2023
  • Report Format: PDF, PPT

Companies Dominating the Antiviral Drugs Landscape

top-features-companies
    • AstraZeneca LP
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • F. Hoffmann-La Roche Ltd
    • GlaxoSmithKline, Plc
    • Bristol Myers Squibb Company
    • Abbott Laboratories
    • Plough Publishing House
    • Merck & Co., Inc
    • Johnson & Johnson Services, Inc
    • AbbVie Inc.
    • Cipla Inc.
    • Dr Reddy’s Laboratories Ltd.

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • Merck & Co., Inc. announced that Molnupiravir, an oral antiviral investigational medicine used to reduce the risk of hospitalization or death.

  •  Johnson & Johnson Services, Inc. declared the introduction of a multi-pronged response against novel Coronavirus. This is also used to determine the coronavirus pathophysiology to help patients survive from 2019-nCoV infection.


Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 473
  • Published Date: Feb 13, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Rising cases of HIV, AIDS, Hepatitis, and STDs among adults are the major factors driving the growth of the antiviral drugs market.

The market is anticipated to attain a CAGR of ~4% over the forecast period, i.e., 2023-2033.

Rising awareness about preventive drug treatment and drug resistance are the challenges affecting the market growth.

The market in North America region is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

The major players in the market are F. Hoffmann-La Roche Ltd, GlaxoSmithKline, Plc, Bristol Myers Squibb Company, Abbott Laboratories, Plough Publishing House, Merck & Co., Inc, Johnson & Johnson Services, Inc, AbbVie Inc., Cipla Inc., Dr Reddy’s Laboratories Ltd.

The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue-generating capacity as well as the new products being launched into the market by the company.

The market is segmented by drug class, indication, type, age group, and by region.

The reverse transcriptase segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying